Skip Ribbon Commands
Skip to main content
Forward Look

Anti-Estrogen Treatment for Post-Menopausal Women

Current guidelines recommend that postmenopausal women with early-stage, hormone receptor-positive breast cancer take one of the following:

• tamoxifen for 10 years;
• an aromatase inhibitor for five years;
• tamoxifen for five years, followed by an aromatase inhibitor for up to five years, for a total of 10 years of hormonal therapy; or
• tamoxifen for two to three years, followed by up to five years of an aromatase inhibitor, for a total of seven to eight years of hormonal therapy.


Receive monthly updates, including information about web exclusives, events, resources, articles and highlights from new issues—direct to your email inbox. Be among the first to hear the latest news from Cancer Today! Click here to sign up!